Earnings News
FONT-SIZE Plus   Neg
Share SHARE

Pre-market Movers For April 10 (ERT, XRIT, SNE, VVUS, VPHM)

RELATED NEWS
Trade SNE now with 

Gainers:

eResearch Technology, Inc. (ERT: Quote) is rising more than 2 percent to $8.05 as it agreed to be acquired by affiliates of Genstar Capital LLC for $8.00 per share in cash in a transaction valued at around $400 million.

X-Rite, Inc (XRIT: Quote) is jumping 38 percent to $5.54. The company has signed a definitive merger agreement to be acquired by Danaher (DHR) for $5.55 per share in cash, or a total of approximately $625 million including the assumption of debt, net of cash.

Decliners:

Sony Corp. (SNE: Quote) is falling 8 percent to $18.45. The company has widened its 2012 net loss forecast, citing a tax charge. However, the company said it expects to return to positive operating results next year on foreign exchange impact.

VIVUS, Inc. (VVUS: Quote) is falling 1 percent to $22.69 based on the news that the FDA had extended Prescription Drug User Fee Act (PDUFA) date for review of the Qnexa New Drug Application from April 17 to July 17, 2012.

ViroPharma Inc. (VPHM: Quote) is falling 19 percent to $23. Watson Pharmaceuticals, Inc. (WPI) announced that it has received FDA approval for its Abbreviated New Drug Application for Vancomycin Hydrochloride Capsules, USP, 125 mg and 250 mg, generic versions of ViroPharma's VANCOCIN HCl capsules. In response, ViroPharma said it intends to file a complaint in the District Court seeking an injunction to set aside the FDA's approval of Vancocin generic versions.

Register
To receive FREE breaking news email alerts for Sony Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.